| 000 | 01421 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250513053514.0 | ||
| 264 | 0 | _c19941223 | |
| 008 | 199412s 0 0 eng d | ||
| 022 | _a1468-2044 | ||
| 024 | 7 |
_a10.1136/adc.71.3.266 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPrice, D A | |
| 245 | 0 | 0 |
_aBiosynthetic human growth hormone treatment in the UK: an audit of current practice. Kabi Pharmacia International Growth Study. _h[electronic resource] |
| 260 |
_bArchives of disease in childhood _cSep 1994 |
||
| 300 |
_a266-71 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFrance |
| 650 | 0 | 4 | _aGermany |
| 650 | 0 | 4 |
_aGrowth Disorders _xdrug therapy |
| 650 | 0 | 4 |
_aGrowth Hormone _xdeficiency |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMedical Audit |
| 650 | 0 | 4 |
_aRecombinant Proteins _xtherapeutic use |
| 650 | 0 | 4 |
_aSweden _xepidemiology |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aTurner Syndrome _xcomplications |
| 650 | 0 | 4 |
_aUnited Kingdom _xepidemiology |
| 700 | 1 | _aJohnston, D I | |
| 700 | 1 | _aBetts, P R | |
| 700 | 1 | _aBuckler, J M | |
| 700 | 1 | _aDonaldson, M D | |
| 773 | 0 |
_tArchives of disease in childhood _gvol. 71 _gno. 3 _gp. 266-71 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1136/adc.71.3.266 _zAvailable from publisher's website |
| 999 |
_c7978837 _d7978837 |
||